11 - 20 of 46 results for: CSI::health ; Currently searching offered courses. You can also include unoffered courses

Healthcare spending is now nearly 18% of the entire GDP of the U.S. economy. The S&P healthcare sector has been one of the best producing segments of the market for the last decade, and growth of healthcare expenditures continue to escalate at a rapid pace. Given the experiences of COVID, every single company must now at least understand how healthcare affects their business. This has triggered an abundance of opportunities for those interested in a career in healthcare management, investing, or entrepreneurialism. The Business of Healthcare-2022-23 will present the current market framework from the eyes of a clinician and with the perspective of the consumer-patient, but with the experience of a successful business builder and investor. Course will begin with the discussion of the channels of distribution of healthcare delivery, from providers, to practitioners, to consumer-facing 'healthcare lite' sectors of the market. Impact of the regulatory environment, with specific focus on the Affordable Care Act and the impending plans to Repeal/Replace, will be evaluated. High-level exploration of international health care markets and how they compare to the American market will be included. Overview of venture and private equity investing will be deeply probed, with many specific market examples of how investors develop an investment thesis, identify specific targets, diligence companies, and close an investment. Discussion around building financial modeling for target acquisitions will be presented, and the course will delve into the burgeoning area of healthcare analytics and outcomes management, including Artificial Intelligence, and its future impact on positioning, reimbursement and clinical outcomes, as well as value-based care. Sectors that will be discussed include: Healthcare services, Healthcare IT, Life Sciences, Pharma and Biotechnology, and Managed Care. The topic of the emerging importance of consumerism will be probed and consumer-directed healthcare related products and services will be explored, e.g. nutraceuticals, wellness, fitness, etc. Course will include preparatory readings, presentations from successful and powerful industry leaders, and robust in-class discussion and case studies requiring student engagement. Final grade will consist of class participation, one minor in-class presentation, and a final paper developing either a new healthcare business start-up proposition or presenting an identified investment target in the healthcare industry. Course will be especially valuable for those interested in a career in starting a healthcare company, healthcare investing, healthcare administration, or other healthcare-related management and goal of class will be provide an in-depth overview of how to get started or advance a professional interest in the industry.

The health care system accounts for almost 20% US GDP and is one of the fastest growing segments of the economy. This two unit class focuses on the interplay and tension between the main players in the health care field - providers of health care services (individual doctors, group practices, integrated health care systems), payors (insurances companies, employers, consumers, and government), patients, and innovator companies (biopharma, medical device, diagnostics, and health care IT). The course is designed for students with a broad diversity of backgrounds and interests who want to better understand the health care business and system. No prior experience in the health care or medical field is assumed or needed. The focus of the class will be primarily on the US health care system, but there will be limited discussion of non-US systems as well. The course is divided into four modules:¿ An overview of the US Health Care System and the interplay between payers, providers, innovators, and patients¿ Provider delivery models, health care information technology, and incentive structures- The relationship between quality, cost, and access- Integrated systems, value-based, and fee for service models- New IT technologies, including electronic data records- The role of information and incentives¿ Innovator business models and issues- Financing and managing new product development- Clinical trial management and gaining regulatory approval- Marketing, reimbursement, and sales strategies- Business models to drive innovation ¿ Health care system reform and comparisons of the structure of the US Health Care system to that of other countries. The class will be taught primarily from the perspective of a business person operating a company rather than that of a policy maker, academic, or investor. While there will be a few lectures to provide background and frameworks for course topics, most classes will involve a case discussion and prominent guest speakers from the health care industry. Speakers will include CEOs, senior executives, and partners from leading companies and venture firms.

(Same as LAW 3006) Legal, social, and ethical issues arising from advances in neuroscience, including effects upon law and society through improvements in predicting illnesses and behaviors, reading minds through neuroimaging, understanding responsibility and consciousness, treating criminal behavior, and cognitive enhancement.

(SAME AS LAW 3001, MGTECON 331) This course provides the legal, institutional, and economic background necessary to understand the financing and production of health services in the U.S. We will discuss the Affordable Care Act , health insurance (Medicare and Medicaid, employer-sponsored insurance, the uninsured), the approval process and IP protection for pharmaceuticals, and antitrust policy. We may discuss obesity and wellness, regulation of fraud and abuse, and medical malpractice. The syllabus for this course can be found at https://syllabus.stanford.edu. Elements used in grading: Participation, attendance, class presentation, and final exam.

Social ecological perspective on health emphasizing how individual health behavior is shaped by social forces. Topics include: biobehavioral factors in health; health behavior change; community health promotion; and psychological aspects of illness, patient care, and chronic disease management. Prerequisites: HUMBIO 3B or PSYCH 1 or consent of the instructor

The study of food, and the nutrients and substances therein. Their action, interaction, and balance in relation to health and disease. Emphasis is on the biological, chemical, and physiological processes by which humans ingest, digest, absorb, transport, utilize, and excrete food. Dietary composition and individual choices are discussed in relationship to the food supply, and to population and cultural, race, ethnic, religious, and social economic diversity. The relationships between nutrition and disease; ethnic diets; vegetarianism; nutritional deficiencies; nutritional supplementation; phytochemicals. The material in this course is an introduction to the field and the target audience is undergraduates. It may be of interest to graduate students unfamiliar with the field. Graduate students enroll in CHPR 130. Undergrads enroll in HUMBIO 130. CHPR master's students must enroll for a letter grade.

We are living in a time of rapid growth in the accessibility and availability of biological and medical data. How can all this data be used to improve human health? In this course, students will look at case studies from diabetes and cancer research to learn how to access publicly available data ranging from genetic, protein and signaling pathway databases to information about clinical trials. Students will apply what they learn about bioinformatics databases to develop a research proposal and presentation on a biology-related topic of their choice. The class will have an interactive format with in-class data analysis activities. Students will gain skills in research methods including accessing, analyzing and presenting data. Assignments will use the R programming language. Prior programming experience is not required. Prerequisites: HUMBIO 2A and HUMBIO 3A or BIO 82 and BIO 83 or consent of instructor

Clinical epidemiological methods relevant to human research in cancer will be the focus. The concepts of risk; case control, cohort, and cross-sectional studies; clinical trials; bias; confounding; interaction; screening; and causal inference will be introduced and applied. Social, political, economic, and ethical controversies surrounding cancer screening, prevention, and research will be considered. HUMBIO 154 courses can be taken separately or as a series. Prerequisites: Human Biology core or Biology Foundations or instructor consent.

Design for Extreme Affordability (fondly called Extreme) is a two-quarter course offered by the d.school through the School of Engineering and the Graduate School of Business. This multidisciplinary project-based experience creates an enabling environment in which students learn to design products and services that will change the lives of the world's poorest citizens. Students work directly with course partners on real world problems, the culmination of which is actual implementation and real impact. Topics include design thinking, product and service design, rapid prototype engineering and testing, business modelling, social entrepreneurship, team dynamics, impact measurement, operations planning and ethics. Possibility to travel overseas during spring break. Previous projects include d.light, Driptech, Earthenable, Embrace, the Lotus Pump, MiracleBrace, Noora Health and Sanku. Periodic design reviews; Final course presentation and expo; industry and adviser interaction. Limited enrollment via application. Must sign up for ME206A and ME206B. See extreme.stanford.edu